Skip to main content
OpenTrials

Clinical trial condition

Neovascular (Wet) Age-related Macular Degeneration

Explore clinical trials studying Neovascular (Wet) Age-related Macular Degeneration. Study availability and eligibility vary by location and protocol.

17 public trials 3 recruiting studies
Refine in advanced search Browse all conditions

Neovascular (Wet) Age-related Macular Degeneration trial results

Completed

Study of the SCD411 Prefilled Syringe for Treating Adults With Wet Age-Related Macular Degeneration, Retinal Vein Occlusion, Diabetic Macular Edema, or Diabetic Retinopathy

NCT07501052

Conditions
Cardiovascular Diseases, Diabetes Complications, Diabetes Mellitus, +14 more
Locations
  • East Florida Eye Institute Stuart, Florida, United States
  • Center for Retina and Macular Disease Winter Haven, Florida, United States
  • University Retina & Macula Associates, P.C Lemont, Illinois, United States
  • Retina Vitreous Surgeons of Central New York, PC Liverpool, New York, United States
View Trial Details
Completed

A Phase 1b Study to Assess the Safety, Tolerability, Pharmacokinetics, and Exploratory Efficacy of Intravitreal OLN324

NCT07484074

Conditions
Diabetic Macular Edema (DME), Eye Diseases, Macular Degeneration, +3 more
Locations
  • Phoenix, AZ Phoenix, Arizona, United States
  • Glendale, CA Glendale, California, United States
  • Pasadena, CA Pasadena, California, United States
  • Sacramento, CA Sacramento, California, United States
View all 30 locations
View Trial Details
Completed

Efficacy Evaluation Study of BAT5906 and Lucentis® in Patients With Macular Degeneration

NCT05439629

Conditions
Eye Diseases, Macular Degeneration, Neovascular (Wet) Age-related Macular Degeneration, +2 more
Locations
  • Affiliated Hospital of Inner Mongolia Medical University Beijing, China
  • Beijing Chao Yang Hospital Beijing, China
  • Beijing Hospital Beijing, China
  • China-Japan Friendship Hospital Beijing, China
View all 48 locations
View Trial Details
Completed

Safety, Tolerability, and Efficacy of Aflibercept in Patients With Neovascular Age-Related Macular Degeneration

NCT04126317

Conditions
Eye Diseases, Macular Degeneration, Neovascular (Wet) Age-related Macular Degeneration, +2 more
Locations
  • Regeneron Study Site Phoenix, Arizona, United States
  • Regeneron Study Site Sun City, Arizona, United States
  • Regeneron Study Site Encino, California, United States
  • Regeneron Study Site Fullerton, California, United States
View all 46 locations
View Trial Details
Completed

Observation of Treatment Patterns With Lucentis® in Real-life Conditions in All Approved Indications

NCT04847895

Conditions
Cardiovascular Diseases, Choroid Diseases, Choroidal Neovascularization, +15 more
Locations
  • Novartis Investigative Site Ettlingen, Baden-Wurttemberg, Germany
  • Novartis Investigative Site Ahaus, Germany
  • Novartis Investigative Site Andernach, Germany
  • Novartis Investigative Site Augsburg, Germany
View all 175 locations
View Trial Details

Related conditions